Literature DB >> 9717255

Action site and cellular effects of cytotoxin VacA produced by Helicobacter pylori.

E Papini1, B Satin, M de Bernard, M Molinari, B Aricò, C Galli, J R Telford, R Rappuoli, C Montecucco.   

Abstract

Cells treated with the VacA toxin from Helicobacter pylori develop large membrane-bound vacuoles that originate from the late endocytotic pathway. Using different experimental approaches, we showed that VacA can induce vacuoles by acting within the cell cytosol. Moreover, separation of VacA-induced vacuoles at an early stage of formation, using a novel isopycnic density ultracentrifugation method, allowed us to show that they resemble a hybrid compartment, containing elements of both late endosomes and lysosomes. Functional defects of the endocytotic pathway were also studied before any macroscopic vacuolation is evident. VacA-intoxicated cells degrade extracellular ligands with reduced efficiency and, at the same time, they secrete acidic hydrolases into the extracellular medium, normally sorted to lysosomes. All these findings indicate that VacA translocates into the cell cytosol where it causes a lesion of the late endosomal/lysosomal compartments, such that protein trafficking across this crucial cross-point is altered with consequences that may be relevant to the pathogenesis of gastroduodenal ulcers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717255     DOI: 10.1007/BF02818613

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  50 in total

1.  The vacuolar ATPase proton pump is present on intracellular vacuoles induced by Helicobacter pylori.

Authors:  E Papini; E Gottardi; B Satin; M de Bernard; P Massari; J Telford; R Rappuoli; S B Sato; C Montecucco
Journal:  J Med Microbiol       Date:  1996-08       Impact factor: 2.472

2.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

3.  Selective recycling of the mannose 6-phosphate/IGF-II receptor to the trans Golgi network in vitro.

Authors:  Y Goda; S R Pfeffer
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

Review 4.  MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

Authors:  R N Germain
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  HLA-DM and MHC class II molecules co-distribute with peptidase-containing lysosomal subcompartments.

Authors:  M Fernandez-Borja; D Verwoerd; F Sanderson; H Aerts; J Trowsdale; A Tulp; J Neefjes
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

6.  Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant.

Authors:  M de Bernard; E Papini; V de Filippis; E Gottardi; J Telford; R Manetti; A Fontana; R Rappuoli; C Montecucco
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

7.  Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein.

Authors:  W Schmitt; R Haas
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

8.  Identification of subcellular compartments involved in biosynthetic processing of cathepsin D.

Authors:  S Rijnboutt; W Stoorvogel; H J Geuze; G J Strous
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

9.  Dense core lysosomes can fuse with late endosomes and are re-formed from the resultant hybrid organelles.

Authors:  N A Bright; B J Reaves; B M Mullock; J P Luzio
Journal:  J Cell Sci       Date:  1997-09       Impact factor: 5.285

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Virulence functions of autotransporter proteins.

Authors:  I R Henderson; J P Nataro
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.

Authors:  Tasia M Pyburn; Nora J Foegeding; Christian González-Rivera; Nathan A McDonald; Kathleen L Gould; Timothy L Cover; Melanie D Ohi
Journal:  Mol Microbiol       Date:  2016-07-08       Impact factor: 3.501

3.  Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin.

Authors:  A Coelho; J R Andrade; A C Vicente; V J Dirita
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization.

Authors:  K J McGovern; T G Blanchard; J A Gutierrez; S J Czinn; S Krakowka; P Youngman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice.

Authors:  Hanan F Ismail; Juan Zhang; Richard G Lynch; Yi Wang; Daniel J Berg
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages.

Authors:  L A Allen; L S Schlesinger; B Kang
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

Review 7.  A meeting of good friends: when the cell biology of prokaryotes and eukaryotes meet.

Authors:  P Sebo
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.629

Review 8.  VacA's Induction of VacA-Containing Vacuoles (VCVs) and Their Immunomodulatory Activities on Human T Cells.

Authors:  Ciara Utsch; Rainer Haas
Journal:  Toxins (Basel)       Date:  2016-06-18       Impact factor: 4.546

Review 9.  Helicobacter pylori Strains and Gastric MALT Lymphoma.

Authors:  Pauline Floch; Francis Mégraud; Philippe Lehours
Journal:  Toxins (Basel)       Date:  2017-04-08       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.